SREBF1 and breast cancer: The clonal formation assay demonstrated that formononetin, under conditions of SREBP1 silencing, attenuated the clonogenic potential of breast cancer cells, whereas Trion-1 did not rescue the clonogenic ability inhibited by formononetin (Figures 5B, C).